| 注册
首页|期刊导航|中国实用妇科与产科杂志|子宫内膜癌及癌前病变的生育力保护和保存

子宫内膜癌及癌前病变的生育力保护和保存

陈晓军

中国实用妇科与产科杂志2026,Vol.42Issue(5):505-510,6.
中国实用妇科与产科杂志2026,Vol.42Issue(5):505-510,6.DOI:10.19538/j.fk2026050106

子宫内膜癌及癌前病变的生育力保护和保存

Fertility preservation and protection in endometrial cancer and precancerous lesions

陈晓军1

作者信息

  • 1. 同济大学附属第十人民医院,上海 200072
  • 折叠

摘要

Abstract

In recent years,the incidence of endometrial cancer and its precancerous lesions has shown a trend of younger onset,placing more women with childbearing desires in a difficult dilemma between cancer treatment and fertility preservation.Although fertility-sparing treatments provide these patients with the possibility of pregnancy,the potential damage to endometrial and ovarian function caused by the disease itself and its treatment cannot be overlooked.Regarding the uterus,prolonged fertility-sparing therapy may lead to endometrial atrophy,fibrosis,and even intrauterine adhesions,significantly impairing embryo implantation.For the ovaries,primary dysfunction,metabolic abnormalities(such as metabolic syndrome and obesity),and the impact of therapeutic drugs may result in reduced ovarian reserve and ovulation disorders,ultimately compromising fertility.Therefore,fertility protection should be performed throughout the entire fertility-sparing treatment process:on one hand,treatment regimens should be optimized to shorten duration and minimize endometrial damage,and emerging technologies such as stem cell,platelet-rich plasma(PRP),and low-intensity focused ultrasound(LIFU)should be appropriately employed to repair the endometrial microenvironment after complete remission;on the other hand,pay attention to ovarian function assessment and intervention,offer fertility preservation options in a timely manner to the high-risk patients,including embryo,oocyte,or ovarian tissue cryopreservation,and improve overall reproductive outcomes through lifestyle modifications and metabolic management.Notably,the exploration of precision diagnosis and treatment based on molecular subtyping and immunotherapy is paving new pathways to expanding the indications for fertility-sparing therapy and enhancing efficacy and safety.Looking ahead,only through an integrated,multidisciplinary approach involving gynecologic oncology,reproductive medicine,endocrinology and genetics and by implementing individualized,life-course comprehensive management can we truly fulfill patients' fertility aspirations while ensuring their life safety.

关键词

子宫内膜癌/子宫内膜不典型增生/生育力保护/生育力保存/保留生育功能治疗

Key words

endometrial cancer/atypical endometrial hyperplasia/fertility protection/fertility preservation/fertility-sparing treatment

分类

医药卫生

引用本文复制引用

陈晓军..子宫内膜癌及癌前病变的生育力保护和保存[J].中国实用妇科与产科杂志,2026,42(5):505-510,6.

基金项目

国家重点研发计划(2025ZD0545900,2025ZD0545902) National Key Research and Development Program of China(2025ZD0545900,2025ZD0545902) (2025ZD0545900,2025ZD0545902)

中国实用妇科与产科杂志

1005-2216

访问量0
|
下载量0
段落导航相关论文